DNA aptamers and use thereof for the treatment of cancer
US12077760B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 16, 2019 |
| Grant date | Sep 3, 2024 |
| Priority date | — |
| Expiry date | Jun 15, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/912
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are DNA aptamers targeting AXL receptor kinase. The DNA aptamers may comprise a thiophosphate backbone and be chemically modified. Further provided herein are methods of use thereof for the treatment of a disease or disorder, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.